REX AMERICAN RESOURCES Corp — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that REX AMERICAN RESOURCES Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $650.49M | Mar 30, 2026 |
| FY2025 | Jan 31, 2025 | $642.49M | Mar 30, 2026 |
| FY2025 | Jan 31, 2024 | $833.38M | Mar 30, 2026 |
| FY2022 | Jan 31, 2023 | $200.17M | Mar 30, 2023 |
| FY2022 | Oct 31, 2022 | $220.28M | Mar 30, 2023 |
| FY2022 | Jul 31, 2022 | $240.33M | Mar 30, 2023 |
| FY2022 | Apr 30, 2022 | $194.23M | Mar 30, 2023 |
| FY2022 | Jan 31, 2022 | $212.02M | Mar 30, 2023 |
| FY2022 | Oct 31, 2021 | $203.07M | Mar 30, 2023 |
| FY2022 | Jul 31, 2021 | $195.68M | Mar 30, 2023 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2019 | Jan 31, 2020 | $417.70M | Apr 1, 2020 |
| FY2019 | Jan 31, 2019 | $485.89M | Apr 1, 2020 |
| FY2019 | Jan 31, 2018 | $452.15M | Apr 1, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Jan 31, 2018 | $109.54M | Mar 29, 2018 |
| FY2017 | Oct 31, 2017 | $121.16M | Mar 29, 2018 |
| FY2017 | Jul 31, 2017 | $108.74M | Mar 29, 2018 |
| FY2017 | Apr 30, 2017 | $113.14M | Mar 29, 2018 |
| FY2017 | Jan 31, 2017 | $121.59M | Mar 29, 2018 |
| FY2017 | Oct 31, 2016 | $116.28M | Mar 29, 2018 |
| FY2017 | Jul 31, 2016 | $115.71M | Mar 29, 2018 |
| FY2017 | Apr 30, 2016 | $100.22M | Mar 29, 2018 |
| FY2016 | Jan 31, 2016 | $107.23M | Mar 27, 2017 |
| FY2016 | Oct 31, 2015 | $110.58M | Mar 27, 2017 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $93.71M | Mar 30, 2026 |
| FY2025 | Jan 31, 2025 | $91.48M | Mar 30, 2026 |
| FY2025 | Jan 31, 2024 | $98.22M | Mar 30, 2026 |
| FY2022 | Jan 31, 2023 | $14.90M | Mar 30, 2023 |
| FY2022 | Oct 31, 2022 | $11.34M | Mar 30, 2023 |
| FY2022 | Jul 31, 2022 | $16.58M | Mar 30, 2023 |
| FY2022 | Apr 30, 2022 | $11.91M | Mar 30, 2023 |
| FY2022 | Jan 31, 2022 | $38.78M | Mar 30, 2023 |
| FY2022 | Oct 31, 2021 | $25.15M | Mar 30, 2023 |
| FY2022 | Jul 31, 2021 | $14.15M | Mar 30, 2023 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Jan 31, 2024 | $60.94M | Mar 29, 2024 |
| FY2024 | Jan 31, 2023 | $27.70M | Mar 29, 2024 |
| FY2024 | Jan 31, 2022 | $52.36M | Mar 29, 2024 |
| FY2020 | Jan 31, 2021 | $3.54M | Apr 12, 2021 |
| FY2020 | Oct 31, 2020 | $8.84M | Apr 12, 2021 |
| FY2020 | Jul 31, 2020 | ($1.75M) | Apr 12, 2021 |
| FY2020 | Apr 30, 2020 | ($7.64M) | Apr 12, 2021 |
| FY2020 | Jan 31, 2020 | $4.40M | Apr 12, 2021 |
| FY2020 | Oct 31, 2019 | ($2.05M) | Apr 12, 2021 |
| FY2020 | Jul 31, 2019 | $2.26M | Apr 12, 2021 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $32.62M | Mar 30, 2026 |
| FY2025 | Jan 31, 2025 | $27.15M | Mar 30, 2026 |
| FY2025 | Jan 31, 2024 | $29.38M | Mar 30, 2026 |
| FY2024 | Jan 31, 2023 | $22.83M | Mar 28, 2025 |
| FY2024 | Jan 31, 2022 | $21.55M | Mar 29, 2024 |
| FY2022 | Jan 31, 2021 | $17.64M | Mar 30, 2023 |
| FY2022 | Jan 31, 2020 | $19.53M | Apr 6, 2022 |
| FY2020 | Jan 31, 2019 | $20.55M | Apr 12, 2021 |
| FY2019 | Jan 31, 2018 | $24.06M | Apr 1, 2020 |
| FY2018 | Jan 31, 2017 | $21.39M | Mar 29, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $117.83M | Mar 30, 2026 |
| FY2025 | Jan 31, 2025 | $64.19M | Mar 30, 2026 |
| FY2025 | Jan 31, 2024 | $127.97M | Mar 30, 2026 |
| FY2024 | Jan 31, 2023 | $54.80M | Mar 28, 2025 |
| FY2024 | Jan 31, 2022 | $91.71M | Mar 29, 2024 |
| FY2022 | Jan 31, 2021 | $8.62M | Mar 30, 2023 |
| FY2022 | Jan 31, 2020 | $10.34M | Apr 6, 2022 |
| FY2020 | Jan 31, 2019 | $47.93M | Apr 12, 2021 |
| FY2019 | Jan 31, 2018 | $40.97M | Apr 1, 2020 |
| FY2018 | Jan 31, 2017 | $69.11M | Mar 29, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $68.44M | Mar 30, 2026 |
| FY2025 | Jan 31, 2025 | $71.32M | Mar 30, 2026 |
| FY2025 | Jan 31, 2024 | $37.66M | Mar 30, 2026 |
| FY2024 | Jan 31, 2023 | $15.58M | Mar 28, 2025 |
| FY2024 | Jan 31, 2022 | $5.13M | Mar 29, 2024 |
| FY2022 | Jan 31, 2021 | $10.41M | Mar 30, 2023 |
| FY2022 | Jan 31, 2020 | $3.78M | Apr 6, 2022 |
| FY2020 | Jan 31, 2019 | $10.78M | Apr 12, 2021 |
| FY2019 | Jan 31, 2018 | $24.02M | Apr 1, 2020 |
| FY2018 | Jan 31, 2017 | $14.21M | Mar 29, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $797.73M | Mar 30, 2026 |
| FY2025 | Jan 31, 2025 | $720.01M | Mar 30, 2026 |
| FY2024 | Jan 31, 2024 | $664.80M | Mar 28, 2025 |
| FY2024 | Jan 31, 2023 | $579.58M | Mar 29, 2024 |
| FY2022 | Jan 31, 2022 | $550.36M | Mar 30, 2023 |
| FY2022 | Jan 31, 2021 | $479.35M | Apr 6, 2022 |
| FY2020 | Jan 31, 2020 | $500.50M | Apr 12, 2021 |
| FY2019 | Jan 31, 2019 | $471.39M | Apr 1, 2020 |
| FY2018 | Jan 31, 2018 | $478.86M | Mar 29, 2019 |
| FY2017 | Jan 31, 2017 | $454.02M | Mar 29, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Jan 31, 2018 | $121.0K | Mar 29, 2019 |
| FY2017 | Jan 31, 2017 | $100.0K | Mar 29, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $610.71M | Mar 30, 2026 |
| FY2025 | Jan 31, 2025 | $560.34M | Mar 30, 2026 |
| FY2024 | Jan 31, 2024 | $513.92M | Mar 28, 2025 |
| FY2024 | Jan 31, 2023 | $447.98M | Mar 29, 2024 |
| FY2022 | Jan 31, 2022 | $430.79M | Mar 30, 2023 |
| FY2022 | Jan 31, 2021 | $384.78M | Apr 6, 2022 |
| FY2020 | Jan 31, 2020 | $401.01M | Apr 12, 2021 |
| FY2019 | Jan 31, 2019 | $392.94M | Apr 1, 2020 |
| FY2018 | Jan 31, 2018 | $381.49M | Mar 29, 2019 |
| FY2017 | Jan 31, 2017 | $340.44M | Mar 29, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $610.32M | Mar 30, 2026 |
| FY2025 | Jan 31, 2025 | $559.99M | Mar 30, 2026 |
| FY2024 | Jan 31, 2024 | $701.76M | Mar 28, 2025 |
| FY2024 | Jan 31, 2023 | $640.83M | Mar 29, 2024 |
| FY2022 | Jan 31, 2022 | $611.61M | Mar 30, 2023 |
| FY2022 | Jan 31, 2021 | $589.99M | Apr 6, 2022 |
| FY2020 | Jan 31, 2020 | $586.99M | Apr 12, 2021 |
| FY2019 | Jan 31, 2019 | $579.56M | Apr 1, 2020 |
| FY2018 | Jan 31, 2018 | $547.91M | Mar 29, 2019 |
| FY2017 | Jan 31, 2017 | $508.21M | Mar 29, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | $188.73M | Mar 30, 2026 |
| FY2025 | Jan 31, 2025 | $196.26M | Mar 30, 2026 |
| FY2024 | Jan 31, 2024 | $223.40M | Mar 28, 2025 |
| FY2024 | Jan 31, 2023 | $69.61M | Mar 28, 2025 |
| FY2024 | Jan 31, 2022 | $229.85M | Mar 29, 2024 |
| FY2022 | Jan 31, 2021 | $144.50M | Mar 30, 2023 |
| FY2022 | Jan 31, 2020 | $179.66M | Apr 6, 2022 |
| FY2020 | Jan 31, 2019 | $188.53M | Apr 12, 2021 |
| FY2018 | Jan 31, 2018 | $190.99M | Mar 29, 2019 |
| FY2017 | Jan 31, 2017 | $188.58M | Mar 29, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2013 | Jan 31, 2014 | $75.73M | Apr 9, 2014 |
| FY2012 | Jan 31, 2013 | $106.93M | Apr 9, 2013 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | 2 | Mar 30, 2026 |
| FY2025 | Jan 31, 2025 | 1 | Mar 30, 2026 |
| FY2025 | Jan 31, 2024 | 1 | Mar 30, 2026 |
| FY2024 | Jan 31, 2023 | 1 | Mar 28, 2025 |
| FY2024 | Jan 31, 2022 | 2 | Mar 29, 2024 |
| FY2022 | Jan 31, 2021 | 0 | Apr 6, 2022 |
| FY2022 | Jan 31, 2020 | 1 | Apr 6, 2022 |
| FY2017 | Jan 31, 2018 | 6 | Mar 29, 2018 |
| FY2016 | Jan 31, 2017 | 1 | Mar 27, 2017 |
| FY2016 | Oct 31, 2016 | 1 | Mar 27, 2017 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | 2 | Mar 30, 2026 |
| FY2025 | Jan 31, 2025 | 1 | Mar 30, 2026 |
| FY2025 | Jan 31, 2024 | 1 | Mar 30, 2026 |
| FY2024 | Jan 31, 2023 | 1 | Mar 28, 2025 |
| FY2024 | Jan 31, 2022 | 2 | Mar 29, 2024 |
| FY2017 | Jan 31, 2018 | 6 | Mar 29, 2018 |
| FY2016 | Jan 31, 2017 | 1 | Mar 27, 2017 |
| FY2016 | Oct 31, 2016 | 1 | Mar 27, 2017 |
| FY2016 | Jul 31, 2016 | 1 | Mar 27, 2017 |
| FY2016 | Apr 30, 2016 | 0 | Mar 27, 2017 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 31, 2026 | 32.94M | Mar 30, 2026 |
| FY2025 | Jan 31, 2025 | 34.39M | Mar 30, 2026 |
| FY2024 | Jan 31, 2024 | 17.50M | Mar 28, 2025 |
| FY2024 | Jan 31, 2023 | 17.39M | Mar 29, 2024 |
| FY2022 | Jan 31, 2022 | 17.76M | Mar 30, 2023 |
| FY2022 | Jan 31, 2021 | 5.99M | Apr 6, 2022 |
| FY2020 | Jan 31, 2020 | 6.29M | Apr 12, 2021 |
| FY2019 | Jan 31, 2019 | 6.27M | Apr 1, 2020 |
| FY2018 | Jan 31, 2018 | 6.57M | Mar 29, 2019 |
| FY2017 | Jan 31, 2017 | 6.56M | Mar 29, 2018 |